JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer

PURPOSE: Adjuvant FOLFOX therapy is an established standard-of-care for resected colon cancer. Peripheral sensory neuropathy (PSN) is regarded as the major toxicity issue related to FOLFOX therapy. There have been a few reports on the recovery status from PSN thereafter. JOIN trial investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, Takayuki, Kotaka, Masahito, Shinozaki, Katsunori, Touyama, Tetsuo, Manaka, Dai, Matsui, Takanori, Ishigure, Kiyoshi, Hasegawa, Junichi, Inoue, Keiji, Munemoto, Yoshinori, Takagane, Akinori, Ishikawa, Hiroshi, Ishida, Hideyuki, Ogata, Yutaka, Oba, Koji, Goto, Koichi, Sakamoto, Junichi, Maehara, Yoshihiko, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820589/
https://www.ncbi.nlm.nih.gov/pubmed/31549217
http://dx.doi.org/10.1007/s00280-019-03957-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820589/
https://www.ncbi.nlm.nih.gov/pubmed/31549217
http://dx.doi.org/10.1007/s00280-019-03957-5

Ejemplares similares